China SXT Pharmaceuticals, Inc. (SXTC) Balance Sheet Annual

China SXT Pharmaceuticals, Inc.

SXTC (NASDAQ)

(%)

Financials
China SXT Pharmaceuticals, Inc. Balance Sheet Statement Annual

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 03-31	2024 03-31	2023 03-31	2022 03-31	2021 03-31	2020 03-31	2019 03-31	2018 03-31	2017 03-31	2016 03-31
Report Filing:	2025-07-31	2024-08-13	2023-07-31	2022-07-18	2021-08-13	2020-07-31	2019-08-15	2018-03-31	2017-03-31	2016-03-31
Total Current Assets	21.3	14.23	19.52	22.45	23.23	19.64	15.59	6.1	4.91	5.73
Cash and Short Term Investments	18.1	12.07	17.37	15.52	13.33	7.29	9.13	0.56	0.066	0.011
Cash & Equivalents	18.1	12.07	17.37	15.52	13.33	7.29	9.13	0.56	0.066	0.011
Short Term Investments	0.138	0	0	0	0	0	0	0	0	0
Receivables	1.9	1.35	1.34	5.53	7.77	10.65	4.93	3.91	3.21	2.36
Inventory	0.828	0.81	0.531	1.02	0.86	0.893	1.01	1.27	1.02	1.72
Other Current Assets	0.469	0.007	0.277	0.385	1.27	0.809	0.517	0.362	0.615	1.64
Total Assets	21.66	23.13	29.55	33.55	34.55	21.7	17.47	7.66	5.43	6.3
Total Non-Current Assets	0.367	8.89	10.03	11.09	11.31	2.07	1.88	1.56	0.526	0.471
Property, Plant and Equipment	0.355	0.565	1.27	1.59	1.79	1.9	1.81	1.49	0.485	0.43
Goodwill and Intangible Assets	0.012	0.019	0.028	0.039	0.046	0.05	0.061	0.061	0.041	0.041
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0.012	0.019	0.028	0.039	0.046	0.05	0.061	0.061	0.041	0.041
Long Term Investments	0	0	0	0	0	-0.441	-0.013	-0.006	0	0
Deferred Tax Assets	0	0	0	0	0.321	0.113	0.014	0.006	0	0
Other Long Term Assets	0	8.31	8.74	9.46	9.16	0.441	0.013	0.006	0	0
Total Current Liabilities	6.01	8.9	14.5	17.12	18.58	12.26	6.32	4.37	3.58	5.55
Accounts Payable	1.16	1.28	1.38	1.48	1.46	1.94	1.69	2.41	1.26	2.89
Notes Payable/Short Term Debt	0.772	2.35	3.39	2.05	0.037	6.69	2.74	0.385	0.302	0.479
Tax Payables	1.03	1.05	1.1	1.17	1.16	0.987	1.06	0.87	0	0
Deferred Revenue	0.059	0.188	0.166	0.077	0.257	0.298	0.058	0.293	0	0.544
Other Current Liabilities	2.99	4.03	8.46	12.35	15.67	2.35	0.771	0.416	2.01	1.64
Total Liabilities	6.22	9.2	14.86	17.12	18.59	12.3	6.36	4.37	3.58	5.55
Total Non-Current Liabilities	0.212	0.295	0.366	0	0.006	0.037	0.042	0	0	0
Total Long Term Debt	0.212	0.295	0.366	0	0.006	0.037	0.042	0	0	0
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non-Current	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0.177	0.236	0.306	0	0	0	0	0	0	0
Other Long Term Liabilities	-0.177	-0.236	-0.306	0	0	0	0	0	0	0
Total Equity	15.44	13.93	14.69	16.42	15.96	9.4	11.11	3.29	1.85	0.743
Non-Controlling Interest	0	0	0	0	0	0	0	0	0	0
Total Stockholders' Equity	15.44	13.93	14.69	16.42	15.96	9.4	11.11	3.29	1.85	0.743
Retained Earnings	-28.02	-24.71	-21.61	-15.69	-9.95	-7.2	3.08	1.54	0.357	-0.828
Accumulated Other Earnings	-1.08	-1.03	-0.198	0.956	0.528	-0.591	0.05	0.257	0.012	0.087
Common Stock	44.53	4.35	0.914	0.162	0.062	0.035	0.023	0.02	0.02	0.02
Preferred Stock	0	0	0	0	0	0	0	0	0	0
Additional Paid in Capital	0	35.32	35.59	30.99	25.32	17.16	7.95	1.46	1.46	1.46
Total Liabilities & Total Equity	21.66	23.13	29.55	33.55	34.55	21.7	17.47	7.66	5.43	6.3
Total Liabilities & Shareholders' Equity	21.66	23.13	29.55	33.55	34.55	21.7	17.47	7.66	5.43	6.3
Total Investments	0.138	0	0	0	0	-0.441	-0.013	-0.006	0	0
Total Debt	0.984	2.65	3.76	2.05	0.043	6.72	2.79	0.385	0.302	0.479
Net Debt	-17.12	-9.42	-13.61	-13.48	-13.29	-0.563	-8.87	-0.175	0.237	0.468

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

China SXT Pharmaceuticals, Inc. Balance Sheet Statement Annual